NCT02979626 Evaluation of Moderate to Severe Influenza Outcomes in Children Status COMPLETED Phase N/A
NCT02972957 A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia Status COMPLETED Phase PHASE4
NCT02964065 A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV) Status COMPLETED Phase PHASE3
NCT02962908 A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine Status COMPLETED Phase PHASE2
NCT02955030 Evaluation of the Safety and Immunogenicity of a Sublingual Influenza Vaccine NSV0001 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02954354 A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza Status COMPLETED Phase PHASE3
NCT02949011 Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications Status COMPLETED Phase PHASE3
NCT02921997 H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses Status COMPLETED Phase PHASE2
NCT02918006 A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine Status COMPLETED Phase PHASE2
NCT02915302 Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children Status COMPLETED Phase PHASE4
NCT02908269 Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations Status COMPLETED Phase PHASE4
NCT02894840 Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults Status COMPLETED Phase PHASE1/PHASE2
NCT02883426 Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease Status TERMINATED Phase PHASE1